Evidence map›Paper›PMID 26991302›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]

Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.

Catarina Savastano, Elisa de Oliveira Silva, Lindyanne Lemos Gonçalves, Jéssica Maria Nery, Naiara Chaves Silva, Amanda Latercia Tranches Dias

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Journal of medical microbiology · 2026
    Review
  2. Article
  3. Article
  4. Characterization and susceptibility of non-albicansFrontiers in public health · 2023
    Observational
  5. Activity ofNanomaterials (Basel, Switzerland) · 2022
    Article
  6. Pharmaceutics · 2021
    Review
  7. Prevalence ofAfrican health sciences · 2020
    Article
  8. Article
  9. In Vitro and In Vivo Anti-Plants (Basel, Switzerland) · 2019
    Article
  10. Article
  11. Activity of the aqueous extract of Schinus terebinthifolius Raddi on strains of the Candida genus.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Catarina SavastanoMicrobiology and Immunology Department, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil.
Elisa de Oliveira SilvaMicrobiology and Immunology Department, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil.
Lindyanne Lemos GonçalvesMicrobiology and Immunology Department, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil.
Jéssica Maria NeryMicrobiology and Immunology Department, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil.
Naiara Chaves SilvaMicrobiology and Immunology Department, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil.
Amanda Latercia Tranches DiasMicrobiology and Immunology Department, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil. Electronic address: amandaltdias@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of the species Candida albicans and non-albicans Candida was evaluated in a Brazilian Tertiary Hospital from the environment and health practitioners. In a 12-month period we had a total positivity of 19.65% of Candida spp. The most recurring non-albicans Candida species was C. glabrata (37.62%), generally considered a species of low virulence, but with a higher mortality rate than C. albicans. Subsequently, C. parapsilosis (25.74%) and C. tropicalis (16.86%) were the second and third most commonly isolated species. Considering the total samples collected from the emergency room and from the inpatient and the pediatric sector, 19.10% were positive for Candida spp., with the predominance of non-albicans Candida species (89.42%). The high percentage of positivity occurred in the hands (24.32%) and the lab coats (21.88%) of the health care assistants. No sample of C. albicans presented a profile of resistance to the drugs. All the non-albicans Candida species presented a decreased susceptibility to miconazole and itraconazole, but they were susceptible to nystatin. Most of the isolates were susceptible to fluconazole and amphotericin B. As expected, a high resistance rate was observed in C. glabrata and C. krusei, which are intrinsically less susceptible to this antifungal agent. The contamination of environmental surfaces by Candida spp. through hand touching may facilitate the occurrence of Candida infections predominantly in immunocompromised patients. In addition to that, the antifungal agents used should be carefully evaluated considering local epidemiologic trends in Candida spp. infections, so that therapeutic choices may be better guided.

Indexed as

Antifungal AgentsBrazilCandidaCandida glabrataCandidiasisCross InfectionDrug Resistance, FungalEquipment and Supplies, HospitalFemaleHealth PersonnelHospitalsHumansMaleMicrobial Sensitivity TestsTertiary Health CareWorkforceAntifungal AgentsAntifungal drugsCandida glabrataCandida spp.Hospital environmentNon-albicans Candida species

Identifiers

PMID26991302
PMCPMC4874588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.